Annual D&A
$14.20 M
-$96.00 K-0.67%
31 December 2023
Summary:
Allogene Therapeutics annual depreciation & amortization is currently $14.20 million, with the most recent change of -$96.00 thousand (-0.67%) on 31 December 2023. During the last 3 years, it has risen by +$6.61 million (+87.17%). ALLO annual D&A is now -0.67% below its all-time high of $14.29 million, reached on 31 December 2022.ALLO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$3.21 M
-$437.00 K-11.99%
30 September 2024
Summary:
Allogene Therapeutics quarterly depreciation & amortization is currently $3.21 million, with the most recent change of -$437.00 thousand (-11.99%) on 30 September 2024. Over the past year, it has dropped by -$365.00 thousand (-10.22%). ALLO quarterly D&A is now -24.40% below its all-time high of $4.24 million, reached on 31 December 2021.ALLO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$13.88 M
-$365.00 K-2.56%
30 September 2024
Summary:
Allogene Therapeutics TTM depreciation & amortization is currently $13.88 million, with the most recent change of -$365.00 thousand (-2.56%) on 30 September 2024. Over the past year, it has increased by +$93.00 thousand (+0.67%). ALLO TTM D&A is now -10.25% below its all-time high of $15.47 million, reached on 30 September 2022.ALLO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.7% | -10.2% | +0.7% |
| 3 y3 years | +87.2% | +37.6% | +72.3% |
| 5 y5 years | +846.6% | +141.5% | +273.3% |
ALLO Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -0.7% | +87.2% | -24.4% | +37.6% | -10.3% | +72.3% |
| 5 y | 5 years | -0.7% | +846.6% | -24.4% | +141.5% | -10.3% | +273.3% |
| alltime | all time | -0.7% | +846.6% | -24.4% | -10.3% |
Allogene Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.21 M(-12.0%) | $13.88 M(-2.6%) |
| June 2024 | - | $3.64 M(+2.5%) | $14.25 M(+0.0%) |
| Mar 2024 | - | $3.56 M(+2.2%) | $14.25 M(+0.3%) |
| Dec 2023 | $14.20 M(-0.7%) | $3.48 M(-2.7%) | $14.20 M(+3.0%) |
| Sept 2023 | - | $3.57 M(-1.9%) | $13.79 M(-2.0%) |
| June 2023 | - | $3.64 M(+3.9%) | $14.08 M(-0.2%) |
| Mar 2023 | - | $3.51 M(+14.3%) | $14.11 M(-1.3%) |
| Dec 2022 | $14.29 M(+36.7%) | $3.07 M(-20.5%) | $14.29 M(-7.6%) |
| Sept 2022 | - | $3.86 M(+5.0%) | $15.47 M(+11.0%) |
| June 2022 | - | $3.67 M(-0.5%) | $13.94 M(+14.0%) |
| Mar 2022 | - | $3.69 M(-13.0%) | $12.23 M(+17.0%) |
| Dec 2021 | $10.45 M | $4.24 M(+82.1%) | $10.45 M(+29.8%) |
| Sept 2021 | - | $2.33 M(+18.6%) | $8.06 M(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $1.96 M(+2.4%) | $7.54 M(+1.0%) |
| Mar 2021 | - | $1.92 M(+4.0%) | $7.46 M(-1.7%) |
| Dec 2020 | $7.59 M(+50.9%) | $1.84 M(+1.9%) | $7.59 M(-0.1%) |
| Sept 2020 | - | $1.81 M(-4.1%) | $7.60 M(+6.8%) |
| June 2020 | - | $1.89 M(-7.6%) | $7.12 M(+11.6%) |
| Mar 2020 | - | $2.04 M(+10.2%) | $6.38 M(+26.8%) |
| Dec 2019 | $5.03 M(+235.1%) | $1.85 M(+39.7%) | $5.03 M(+35.2%) |
| Sept 2019 | - | $1.33 M(+15.6%) | $3.72 M(+28.5%) |
| June 2019 | - | $1.15 M(+65.3%) | $2.89 M(+31.8%) |
| Mar 2019 | - | $695.00 K(+27.1%) | $2.19 M(+46.3%) |
| Dec 2018 | $1.50 M | $547.00 K(+8.7%) | $1.50 M(+57.4%) |
| Sept 2018 | - | $503.00 K(+11.8%) | $953.00 K(+111.8%) |
| June 2018 | - | $450.00 K(>+9900.0%) | $450.00 K(>+9900.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
FAQ
- What is Allogene Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Allogene Therapeutics?
- What is Allogene Therapeutics annual D&A year-on-year change?
- What is Allogene Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly D&A year-on-year change?
- What is Allogene Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Allogene Therapeutics?
- What is Allogene Therapeutics TTM D&A year-on-year change?
What is Allogene Therapeutics annual depreciation & amortization?
The current annual D&A of ALLO is $14.20 M
What is the all time high annual D&A for Allogene Therapeutics?
Allogene Therapeutics all-time high annual depreciation & amortization is $14.29 M
What is Allogene Therapeutics annual D&A year-on-year change?
Over the past year, ALLO annual depreciation & amortization has changed by -$96.00 K (-0.67%)
What is Allogene Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of ALLO is $3.21 M
What is the all time high quarterly D&A for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly depreciation & amortization is $4.24 M
What is Allogene Therapeutics quarterly D&A year-on-year change?
Over the past year, ALLO quarterly depreciation & amortization has changed by -$365.00 K (-10.22%)
What is Allogene Therapeutics TTM depreciation & amortization?
The current TTM D&A of ALLO is $13.88 M
What is the all time high TTM D&A for Allogene Therapeutics?
Allogene Therapeutics all-time high TTM depreciation & amortization is $15.47 M
What is Allogene Therapeutics TTM D&A year-on-year change?
Over the past year, ALLO TTM depreciation & amortization has changed by +$93.00 K (+0.67%)